SCHEMBL3375884

SCHEMBL3375884

NC12CC3CC(C1)CC(NC(=O)c1cccc(OC(F)F)c1)(C3)C2

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.77
ATM Q13315 1/20 0.77
FAAH O00519 4/20 0.58
CNR2 P34972 4/20 0.58
MEN1 O00255 2/20 0.58
EPHX2 P34913 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.48
RAB9A P51151 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
PBK Q96KB5 1/20 0.44
TSHR P16473 1/20 0.44
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
DPP8 Q6V1X1 1/20 0.43
DPP9 Q86TI2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2638888 0.88 CNR2 (0.76) KMT2AATMFAAHCNR2MEN1
SCHEMBL2638957 0.87 KMT2A (1.00) KMT2AATMFAAHCNR2MEN1
SCHEMBL3375880 0.87 KMT2A (0.73) KMT2AATMFAAHCNR2MEN1
SCHEMBL3375702 0.85 FAAH (0.58) KMT2AATMFAAHCNR2MEN1
SCHEMBL2638077 0.84 FAAH (0.57) KMT2AATMFAAHCNR2MEN1
SCHEMBL1578168 0.84 GRM5 (0.55) KMT2AATMFAAHCNR2MEN1
SCHEMBL3375838 0.83 FAAH (0.56) KMT2AATMFAAHCNR2MEN1
SCHEMBL3376422 0.82 FAAH (0.74) KMT2AATMFAAHCNR2MEN1
SCHEMBL3377753 0.81 FAAH (0.54) KMT2AATMFAAHCNR2MEN1
SCHEMBL3377740 0.81 FAAH (0.54) KMT2AATMFAAHCNR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2310356-B1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME LUNDBECK & CO AS H (DK) 2013-08-14 EP claimed
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 US claimed
US-8389519-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2013-03-05 US disclosed
US-20120270873-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2012-10-25 US disclosed
US-8198275-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2012-06-12 US disclosed
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270873-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, PDE3B, ADM2 KMT2A 3173/4885ATM 2759/4885FAAH 2836/4885
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, ADM2, PDE3B KMT2A 3089/4885ATM 2684/4885FAAH 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.